Essex Bio-Technology Limited (1061.HK)
HKD 2.76
(0.37%)
HKD 2.76
(0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 333.88 Million | 382.78 Million | 409.16 Million | 299.23 Million | 232.85 Million | 200.87 Million |
| Net Income | 275.25 Million | 260.34 Million | 394.45 Million | 250.85 Million | 351.76 Million | 273.05 Million |
| Depreciation & Amortization | 59.5 Million | 41.91 Million | 32.97 Million | 27.59 Million | 27.79 Million | 19.64 Million |
| Deferred income taxes | - | - | 42.45 Million | -51.45 Million | -55.26 Million | - |
| Stock-based compensation | - | 87.04 Thousand | 264.49 Thousand | 696.74 Thousand | 1.28 Million | 2.34 Million |
| Change in working capital | -51.63 Million | 92.51 Million | -60.34 Million | 77.69 Million | -96.09 Million | -35.34 Million |
| Other non-cash items | 50.75 Million | -12.07 Million | -636.48 Thousand | -6.15 Million | 3.36 Million | -58.82 Million |
| Investing Cash Flow | -127.56 Million | -302.03 Million | -280.08 Million | -343.26 Million | -179.6 Million | -144.89 Million |
| Investments in PPE | -128.04 Million | -282.91 Million | -244.53 Million | -317.64 Million | -165.82 Million | -99.32 Million |
| Acquisitions | 105.64 Thousand | 573.58 Thousand | 31.55 Thousand | -2.17 Million | -419.38 Thousand | 80.45 Million |
| Investment purchases | -4.99 Million | -146.99 Thousand | -2.93 Million | -1.37 Million | -3.9 Million | -71.19 Million |
| Sales/Maturities of investments | 5.37 Million | - | -174.23 Million | 8.32 Million | 52.72 Million | 19.39 Million |
| Other Investing Activities | 62.61 Million | -19.54 Million | 141.58 Million | -30.39 Million | -62.17 Million | -74.23 Million |
| Financing Cash Flow | -293.99 Million | -169.11 Million | -73.13 Million | 149.48 Million | 113.35 Million | 24.94 Million |
| Debt repayment | -238.24 Million | -81.59 Million | -55.12 Million | -19.25 Million | -162.26 Million | -29.5 Million |
| Dividends payments | -39.92 Million | -54.52 Million | -51.88 Million | -28.89 Million | -39.34 Million | -31.4 Million |
| Common Stock Repurchased | -12.59 Million | -14.79 Million | -8.68 Million | -4.37 Million | -4.32 Million | - |
| Common Stock Issuance | - | - | 1.88 Million | - | 336.3 Thousand | 35.09 Million |
| Other Financing Activities | -3.23 Million | -18.19 Million | 40.67 Million | 202 Million | 318.95 Million | 50.76 Million |
| Accounts receivables | -131.74 Million | 200.63 Million | -169.16 Million | 197.16 Million | -198.69 Million | -150.85 Million |
| Accounts payables | 70.89 Million | -105.55 Million | 80.57 Million | -65.01 Million | 108.39 Million | 85.77 Million |
| Inventory | 16.79 Million | 9.49 Million | 8.68 Million | -40.11 Million | 2.62 Million | 27.72 Million |
| Other working capital | -7.57 Million | -12.05 Million | 19.55 Million | -14.34 Million | -8.42 Million | 2.01 Million |
| Cash at beginning of period | 610.7 Million | 671.33 Million | 599.78 Million | 473.34 Million | 311.09 Million | 240.62 Million |
| Cash at end of period | 513.25 Million | 543.48 Million | 671.33 Million | 599.78 Million | 473.34 Million | 311.09 Million |
| Capital Expenditure | -128.04 Million | -282.91 Million | -244.53 Million | -317.64 Million | -165.82 Million | -99.32 Million |
| Effect of forex changes on cash | -8.58 Million | -39.49 Million | 15.6 Million | 20.98 Million | -4.36 Million | -10.44 Million |
| Net cash flow / Change in cash | -97.45 Million | -127.84 Million | 71.55 Million | 126.44 Million | 162.24 Million | 70.47 Million |
| Free Cash Flow | 205.84 Million | 99.87 Million | 164.62 Million | -18.4 Million | 67.03 Million | 101.55 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 157.44 Million | 275.25 Million | 105.44 Million | 169.81 Million | 260.34 Million | 86.18 Million |
| Depreciation & Amortization | 26.48 Million | 59.5 Million | 28.48 Million | 31.02 Million | 41.91 Million | 21.23 Million |
| Deferred income taxes | - | - | - | - | - | -7.03 Million |
| Stock-based compensation | - | - | - | - | 87.04 Thousand | 49.00 |
| Change in working capital | -70.85 Million | -51.63 Million | 39.31 Million | -90.95 Million | 92.51 Million | 22.95 Million |
| Other non-cash items | 18.59 Million | 50.75 Million | 21.57 Million | 192.25 Million | -12.07 Million | 24.32 Million |
| Investing Cash Flow | -40.82 Million | -127.56 Million | -50.08 Million | -77.47 Million | -302.03 Million | -118.52 Million |
| Investments in PPE | -9.47 Million | -128.04 Million | -55.01 Million | -73.02 Million | -282.91 Million | -107.68 Million |
| Acquisitions | 467 Thousand | 105.64 Thousand | 104.64 Thousand | 1000.00 | 573.58 Thousand | 59.25 Thousand |
| Investment purchases | -2.16 Million | -4.99 Million | -4.46 Million | -538 Thousand | -146.99 Thousand | -3.04 Million |
| Sales/Maturities of investments | 4.48 Million | 5.37 Million | 5.37 Million | - | - | - |
| Other Investing Activities | -31.35 Million | 62.61 Million | 3.91 Million | -3.91 Million | -19.54 Million | -7.84 Million |
| Financing Cash Flow | 5.94 Million | -293.99 Million | -233.72 Million | -60.27 Million | -169.11 Million | -65.45 Million |
| Debt repayment | -34.72 Million | -238.24 Million | -197.22 Million | -41.02 Million | -81.59 Million | -32.4 Million |
| Dividends payments | -25.53 Million | -39.92 Million | -25.65 Million | -14.26 Million | -54.52 Million | -22.91 Million |
| Common Stock Repurchased | -107 Thousand | -12.59 Million | -8.91 Million | -3.68 Million | -14.79 Million | -8.91 Million |
| Common Stock Issuance | - | - | - | 56.05 Million | - | 50.39 Million |
| Other Financing Activities | -3.13 Million | -3.23 Million | -203.73 Million | -11.34 Million | -18.19 Million | -42.69 Million |
| Accounts receivables | -63.46 Million | -131.74 Million | 31.52 Million | -163.27 Million | 200.63 Million | 41.78 Million |
| Accounts payables | 9.31 Million | 70.89 Million | 7.48 Million | 63.41 Million | -105.55 Million | -1.63 Million |
| Inventory | -280 Thousand | 16.79 Million | 5.21 Million | 11.57 Million | 9.49 Million | -4.71 Million |
| Other working capital | -7.1 Million | -7.57 Million | -4.9 Million | -2.66 Million | -12.05 Million | -12.46 Million |
| Cash at beginning of period | 513.25 Million | 610.7 Million | 605.95 Million | 610.7 Million | 671.33 Million | 666.32 Million |
| Cash at end of period | 598.41 Million | 513.25 Million | 513.25 Million | 605.95 Million | 543.48 Million | 610.7 Million |
| Capital Expenditure | -9.47 Million | -128.04 Million | -55.01 Million | -73.02 Million | -282.91 Million | -107.68 Million |
| Effect of forex changes on cash | -8.22 Million | -8.58 Million | 5.76 Million | -14.35 Million | -39.49 Million | -17.1 Million |
| Net cash flow / Change in cash | 85.16 Million | -97.45 Million | -92.7 Million | -4.74 Million | -127.84 Million | -55.62 Million |
| Free Cash Flow | 122.18 Million | 205.84 Million | 127.06 Million | 78.78 Million | 99.87 Million | 39.97 Million |
MUR
ZTLLF
TBR
CUSI
TEM
KENNAMET